CK2-IN-4
CK2-IN-4 (compound 5) is a protein kinase (CK2) inhibitor (IC50=8.6 µM) . CK2-IN-4 has good potential for research in the areas of cancer, viral infections and glomerulonephritis[1].
Product Specifications
CAS Number
[313985-59-0]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Casein Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ck2-in-4.html
Purity
99.24
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C(C2=CSC(NC3=CC=CC=C3)=N2)=CC4=CC([N+]([O-])=O)=CC=C4O1
Molecular Formula
C18H11N3O4S
Molecular Weight
365.36
Precautions
H302, H315, H319
References & Citations
[1]Nakanishi I, et al. Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening. Eur J Med Chem. 2015;96:396-404.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15362261 1 Vial
Lentiviral human SFSWAP sgRNA gene knockout kit - Lentiviral human SFSWAP sgRNA gene knockout kit (plasmid)
Ask
View Details 
MBS6506058-01 0.2 mL
WNK1, CT (Serine/Threonine-protein Kinase WNK1, Protein Kinase With No Lysine 1, hWNK1, PRKWNK1, Protein Kinase, Lysine Deficient 1, Kinase Deficient Protein, Erythrocyte 65kD Protein, p65, KDP, KIAA0344) (PE)
Ask
View Details MBS6506058-02 5x 0.2 mL
WNK1, CT (Serine/Threonine-protein Kinase WNK1, Protein Kinase With No Lysine 1, hWNK1, PRKWNK1, Protein Kinase, Lysine Deficient 1, Kinase Deficient Protein, Erythrocyte 65kD Protein, p65, KDP, KIAA0344) (PE)
Ask
View Details